Subscale analysis of quality of life in patients with systemic lupus erythematosus: Association with Depression, fatigue, disease activity and damage

Clinical and Experimental Rheumatology

Volumn 30, Issue 5, 2012, Pages 665-672

  Choi, S T ^a   Kang, J I ^b   Park, I H ^c   Lee, Y W ^d   Song, J S ^a   Park, Y B ^e   Lee, S K ^e  

^a Chung Ang University   (South Korea)

^b Yonsei University   (South Korea)

^c Catholic Kwandong University   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

^e Yonsei University College of Medicine   (South Korea)

Author keywords

Damage; Disease activity; Glucocorticoid; Quality of life; SLE

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT INVENTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROFILE OF MOOD STATES; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AFFECT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EMOTIONS; FATIGUE; FEMALE; GLUCOCORTICOIDS; HUMANS; LINEAR MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84870279263     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. CERVERA R, KHAMASHTA M, FONT J et al.: Morbidity and mortality in systemic lupus erythematosus during a 10-year period. A comparison of early and late manifestations in a cohort of 1, 000 patients. Medicine 2003;82:299-308.
2. KOZORA E, ELLISON MC, WEST S: Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American college of rheumatology SLE neuropsychological battery. Arthritis Rheum 2006;55:628-35.
3. JUMP BL, ROBINSON ME, ARMSTRONG AE, BARNES EV, KILBOURN KM, RICHARDS HB: Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 2005;32:1699-705.
4. NERY FG, BORBA EF, HATCH JP, SOARES JC, BONFÁ E, NETO FL: Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry 2007;48:14-9.
5. IXHIKURA R, MORIMOTO N, TANAKA K et al.: Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol 2001;20:394-400.
6. IABONI A, IBANEZ D, GLADMAN DD, UROWITZ MB, MOLDOFSKY H: Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol 2006;33:2453-7.
7. STOLL T, GORDON C, SEIFERT B et al.: Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997;24:1608-14.
8. MILLIGAN SE, HOM DL, BALLOU SP, PERSSE LJ, SVILAR GM, COULTON CJ: An assessment of the health assessment questionnaire functional ability index among women with systemic lupus erythematosus. J Rheumatol 1993;20:972-6.
9. BURCKHARDT CS, ARCHENHOLTZ B, BJELLE A: Measuring the quality of life of women with rheumatoid arthritis or systemic lupus erythematosus: a Swedish version of the quality of life scale (QOLS). Scand J Rheumatol 1992;21:190-5.
10. WEBSTER K, CELLA D, YOST K: The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation. Health Qual Life Outcomes 2003;16:79.
11. CELLA DF, DINEEN K, ARNASON B et al.: Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996;47:129-39.
12. TAN EM, COHEN AS, FRIES JF et al:. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. BOMBARDIER C, GLADMAN DD, UROWITZ MB et al:. Derivation of the SLEDAI. A disease activity index for lupus patient. The committee on prognosis studies in SLE. Arthritis Rheum 1992;35:630-40.
14. GLADMAN DD, UROWITZ MB, GOLDSMITH CH et al:. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:809-13.
15. RODLOFF LS: The CES-D scale: a self-reported depression scale for research in the general population. Appl Psychol Mess 1977;1:385-401.
16. MCNAIR DM, LORR M, DROPPLEMAN LF: POMS Manual: profile of Mood States, San Diego, California. Educational and Industrial Testing Service, 1992.
17. WYSENBEEK AJ, LEIBOVICI L, WEINBERGER A, GUEDJ D: Fatigue in systemic lupus erythematosus: prevalence and relation to disease expression. Br J Rheumatol 1993;32:620-3.
18. TORRENTE-SEGARRA V, CARBONELLABELLÓ J, CASTRO-OREIRO S, MANRESA DOMÍNGUEZ JM: Association between fibromyalgia and psychiatric disorders in systemic lupus erythematosus. Clin Exp Rheumatol 2010;28(Suppl. 63):S22-6.
19. VAN OERS ML, BOSSEMA ER, THOOLEN BJ et al:. Variability of fatigue during the day in patients with primary Sjögren's syndrome, systemic lupus erythematosus, and rheumatoid arthritis. Clin Exp Rheumatol 2010;28:715-21.
20. WARD MM, MARX AS, BARRY NN: Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology 2002;41:184-8.
21. MCELHONE K, ABBOTT J, THE L-S: A review of health related quality of life in systemic lupus erythematosus. Lupus 2006;15:633-43.
22. LIM L, RON MA, ORMEROD IEC et al:. Psychiatric and neurological manifestations in systemic lupus erythematosus. Q J Med 1988;66:27-38.
23. th ed. Rheumatology. Elsevier; 2008. 411-9.
24. BUTTGEREIT F, STRAUB RH, WEHLING M, BURMESTER GR: Glucocorticoids in the treatment of rheumatic diseases. Arthritis Rheum 2004;50:3408-17.
25. STEIN H, WALTERS K, DILLON A, SCHULZER M: Systemic lupus erythematosus-a medical and social profile. J Rheumatol 1986;13:570-6.
26. KUEHNER C, BUERGER C: Determinants of subjective quality of life in depressed patients: The role of self-esteem, response styles, and social support. J Affect Disord 2005;86:205-13.
27. BAE SC, HASHIMOTO H, KARLSON EW, LIANG MH, DALTROY LH: Variable effects of social support by race, economic status, and disease activity in systemic lupus erythematosus. J Rheumatol 2001;28:1245-51.
28. MCELHONE K, CASTELINO M, ABBOTT J et al:. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematous. J Rheumatol 2010;37:2273-9.
29. THUMBOO J, FONG KY, CHAN SP et al:. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 2000;27:1414-20.
30. VU TV, ESCALANTE A: A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease. J Rheumatol 1999;26:2595-601.
31. DORIA A, RINALDI S, ERMANI M et al:. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology 2004;43:1580-6.
32. STOLL T, GORDON C, SEIFERT B et al:. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol 1997;24:1608-14.
33. DORIA A, RINALDI S, ERMANI M et al:. Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology 2004;43:1580-6.
34. DOBKIN PL, FORTIN PR, JOSEPH L, ESDAILE JM, DANOFF DS, CLARKE A: Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res 1998;11:23-31.
35. SEAWELL AH, DANOFF-BURG S: Psychosocial research on systemic lupus erythematosus: a literature review. Lupus 2004;14:891-9.
36. KARLSON E, DALTROY L, LEW R et al:. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 1995;38:267-73.